Five-year outcomes of ADHD diagnosed in adulthood.


Journal

Scandinavian journal of psychology
ISSN: 1467-9450
Titre abrégé: Scand J Psychol
Pays: England
ID NLM: 0404510

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 23 04 2020
accepted: 21 09 2020
pubmed: 21 11 2020
medline: 20 5 2021
entrez: 20 11 2020
Statut: ppublish

Résumé

There is a dearth of long-term follow-up studies of adults diagnosed with ADHD. Here, the aim was to evaluate long-term outcomes in a group of ADHD patients diagnosed in adulthood and receiving routine psychiatric health care. Adults diagnosed with any type of ADHD (n = 52) and healthy controls (n = 73) were assessed at baseline and at a 5-year follow-up, using Global Assessment of Functioning (GAF), Clinical Global Impression (CGI), Brown ADD Scale (BADDS) and Adult ADHD Self-Report Scale (ASRS). A multivariate regression method was used to identify factors predicting 5-year outcomes, including baseline ratings, medication intensity, comorbidity, intelligence quotient (IQ), age, and sex. After 5 years, ADHD patients reported fewer and/or less severe symptoms compared to baseline, but remained at clinically significant symptom levels and with functional deficits. Baseline self-reports of ADHD symptoms predicted their own 5-year outcome and low baseline functioning level predicted improved global functioning at follow-up. Factors previously reported to predict short-term outcomes (i.e., medication, comorbidity, IQ, age, and sex) did not anticipate long-term outcomes in present study.

Identifiants

pubmed: 33216369
doi: 10.1111/sjop.12692
pmc: PMC7839718
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-24

Subventions

Organisme : LUA/ALF agreement
ID : ALF 20170019
Organisme : LUA/ALF agreement
ID : ALFGBG-716801
Organisme : Forskningsrådet om Hälsa, Arbetsliv och Välfärd
ID : 2018-02653

Informations de copyright

© 2020 The Authors. Scandinavian Journal of Psychology published by Scandinavian Psychological Associations and John Wiley & Sons Ltd.

Références

Curr Med Res Opin. 2011;27 Suppl 2:23-33
pubmed: 21973229
Ups J Med Sci. 2018 Dec;123(4):230-236
pubmed: 30373435
Biol Psychiatry. 2005 Jun 1;57(11):1442-51
pubmed: 15950019
J Atten Disord. 2013 Nov;17(8):655-9
pubmed: 22408135
Eur Psychiatry. 2019 Feb;56:14-34
pubmed: 30453134
J Psychiatr Res. 2011 Feb;45(2):150-5
pubmed: 20656298
J Atten Disord. 2018 Jan;22(1):3-13
pubmed: 25376193
PLoS One. 2018 Sep 26;13(9):e0204516
pubmed: 30256837
J Neural Transm (Vienna). 2017 Sep;124(9):1135-1143
pubmed: 28656371
Lancet Psychiatry. 2016 Dec;3(12):1157-1165
pubmed: 27745869
Am J Psychiatry. 2015 Oct;172(10):967-77
pubmed: 25998281
BMC Med. 2012 Sep 04;10:99
pubmed: 22947230
Int J Methods Psychiatr Res. 2008;17(1):45-54
pubmed: 18286465
Ann Gen Psychiatry. 2010 May 07;9:20
pubmed: 20459646
Int Psychogeriatr. 2013 Apr;25(4):667-75
pubmed: 23237190
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
J Psychiatr Pract. 2002 Mar;8(2):99-111
pubmed: 15985863
N Engl J Med. 2012 Nov 22;367(21):2006-14
pubmed: 23171097
Ann Clin Psychiatry. 2006 Jul-Sep;18(3):145-8
pubmed: 16923651
Psychol Bull. 2015 Jul;141(4):858-900
pubmed: 25915035
J Clin Psychiatry. 2010 Dec;71(12):1590-7
pubmed: 20584517
Brain. 2014 Sep;137(Pt 9):2423-8
pubmed: 24916335
J Atten Disord. 2016 Oct;20(10):845-54
pubmed: 24271945
J Clin Psychiatry. 2013 Jan;74(1):e87-93
pubmed: 23419235
Community Ment Health J. 1997 Feb;33(1):35-41
pubmed: 9061261
J Pers Soc Psychol. 2002 Aug;83(2):451-469
pubmed: 12150240
J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):484-500
pubmed: 19318991
Front Psychiatry. 2012 Jan 18;2:84
pubmed: 22279437
Wiley Interdiscip Rev Cogn Sci. 2015 Jan;6(1):39-52
pubmed: 25558298
Neuropsychology. 2004 Jul;18(3):485-503
pubmed: 15291727
Lancet Psychiatry. 2018 Sep;5(9):691-692
pubmed: 30097391
Cochrane Database Syst Rev. 2015 Nov 25;(11):CD009885
pubmed: 26599576
Psychol Med. 2006 Feb;36(2):159-65
pubmed: 16420712
Eur Arch Psychiatry Clin Neurosci. 2018 Jun;268(4):337-347
pubmed: 29143159
JAMA Psychiatry. 2019 Nov 1;76(11):1141-1149
pubmed: 31389973
Am J Psychiatry. 1993 Jun;150(6):885-90
pubmed: 8494063
Arch Gen Psychiatry. 1999 Dec;56(12):1073-86
pubmed: 10591283
J Atten Disord. 2019 Oct;23(12):1416-1426
pubmed: 26838558
Psychol Med. 2015 Jul;45(10):2045-56
pubmed: 25612927
Br J Psychiatry. 2007 Jan;190:4-5
pubmed: 17197649
Scand J Psychol. 2021 Feb;62(1):13-24
pubmed: 33216369
JAMA Psychiatry. 2014 Mar;71(3):319-25
pubmed: 24477798
J Atten Disord. 2016 Apr;20(4):295-305
pubmed: 23698916
Health Qual Life Outcomes. 2012 May 14;10:47
pubmed: 22583562
Atten Defic Hyperact Disord. 2017 Mar;9(1):47-65
pubmed: 27866355
J Atten Disord. 2018 Apr;22(6):523-534
pubmed: 26396145
Lancet. 2015 May 30;385(9983):2190-6
pubmed: 25726514
J Am Acad Child Adolesc Psychiatry. 2016 Nov;55(11):937-944.e4
pubmed: 27806861
J Clin Psychopharmacol. 2012 Oct;32(5):645-52
pubmed: 22926598
Br J Psychiatry. 2007 May;190:402-9
pubmed: 17470954
Mol Psychiatry. 2019 Apr;24(4):562-575
pubmed: 29892054
Lancet Psychiatry. 2018 Sep;5(9):727-738
pubmed: 30097390
J Atten Disord. 2002 Jan;5(3):155-64
pubmed: 11911008
Pediatrics. 2004 Apr;113(4):754-61
pubmed: 15060224
J Clin Psychopharmacol. 2017 Dec;37(6):689-696
pubmed: 29049077
Biol Psychiatry. 2003 Jun 1;53(11):1028-42
pubmed: 12788248
J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):989-1002
pubmed: 17667478
Eur Arch Psychiatry Clin Neurosci. 2007 Oct;257(7):371-7
pubmed: 17902010
Lancet Psychiatry. 2016 Jun;3(6):568-78
pubmed: 27183901
Nat Rev Dis Primers. 2015 Aug 06;1:15020
pubmed: 27189265
J Child Psychol Psychiatry. 2017 Jun;58(6):663-678
pubmed: 28295312
Psychiatr Serv. 2005 Apr;56(4):434-8
pubmed: 15812093
Am J Psychiatry. 2000 May;157(5):816-8
pubmed: 10784477
Curr Dir Psychol Sci. 2008 Feb 1;17(1):31-35
pubmed: 19756219
JAMA Psychiatry. 2016 Jul 1;73(7):713-20
pubmed: 27192174
J Clin Psychiatry. 2016 Feb;77(2):232-9
pubmed: 26761266
Biol Psychiatry. 2009 Jan 1;65(1):46-54
pubmed: 19006789
Eur Child Adolesc Psychiatry. 2016 Sep;25(9):1007-17
pubmed: 26837866
Acta Psychiatr Scand. 2013 Jul;128(1):70-7
pubmed: 22943458

Auteurs

Elin Nylander (E)

Department of Psychology, University of Gothenburg, Gothenburg, Sweden.

Orestis Floros (O)

ADHD Unit, Sankt Görans Hospital, Stockholm, Sweden.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Timea Sparding (T)

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

Eleonore Rydén (E)

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

Stefan Hansen (S)

Department of Psychology, University of Gothenburg, Gothenburg, Sweden.

Mikael Landén (M)

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Department of Medical Epidemiology and Biostatics, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH